Identification of Immune-related lncRNA Signatures with Prognostic Connotation in Multi-Cancer Setting

Julie Valerie Caroline M Decock (Inventor), Wouter Hendrickx (Inventor), Raghvendra Mall (Inventor)

Research output: Patent

Abstract

The present disclosure provides a method comprised of one or a combination of ir-lncRNA signatures to predict the clinical outcome of cancer patients, improve prognostic stratification of patients and guide cancer treatment decisions.

Original languageEnglish
Patent numberUS2023348994
IPCC12Q 1/ 6886 A I
Priority date28/04/23
Publication statusPublished - 2 Nov 2023

Fingerprint

Dive into the research topics of 'Identification of Immune-related lncRNA Signatures with Prognostic Connotation in Multi-Cancer Setting'. Together they form a unique fingerprint.

Cite this